top of page
    • 1 min read

Novo Nordisk to launch once-a-week insulin regime for Indian patients

In a major breakthrough, Denmark-based Novo Nordisk is working on a once-a-week insulin regime for Indian patients. The pharmaceuticals major is conducting trials in 27 sites involving 217 patients in India, said Vikrant Shrotriya, India managing director and corporate vice president, Novo Nordisk.




Comments

bottom of page